Boyd J, Sonoda Y, Federici MG, et al. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA 2000;283:2260– 2265.
68.
Bacolod MD, Schemmann GS, Giardina SF, et al. Emerging paradigms in cancer genetics: some important findings from high- density single nucleotide polymorphism array studies. Cancer Res 2009;69:723–727.
69.
Goode EL, Maurer MJ, Sellers TA, et al. Inherited determinants of ovarian cancer survival. Clin Cancer Res 2010;16:995–1007.
70.
Notaridou M, Quaye L, Dafou D, et al. The Australian Ovarian Cancer Study Group/Australian Cancer Study (Ovarian Cancer). Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer 2011;128: 2063–2074.
71.
The Cancer Genome Atlas. Available at: http://en.wikipedia.org/ wiki/The Cancer Genome Atlas. Accessed April 28, 2011.
72.
Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061–1068.
73.
Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010;17:98–110 74.
National Cancer Institute. The Cancer Genome Atlas. Available at: http://cancergenome.nih.gov./ Accessed April 28, 2011.
75.
Boyer CM, Knapp RC, Bast RC Jr. Biology and immunology. In: Berek JS, Hacker NF, eds. Practical gynecologic oncology, 2nd ed. Baltimore, MD: Williams & Wilkins, 1994:75–115.
76.
Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1978;256:495–497.
77.
Di Giovine FS, Duff GW. Interleukin 1: the first interleukin. Immunol Today 1990;11:13–20.
78.
Hirano T, Akira S, Taga T, et al. Biological and clinical aspects of interleukin 6. Immunol Today 1990;11:443–449.
79.
Watson JM, Sensintaffar JL, Berek JS, et al. Epithelial ovarian cancer cells constitutively produce interleukin-6 (IL-6). Cancer Res 1990;50:6959–6965.
80.
Berek JS, Chang C, Kaldi K, et al. Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am J Obstet Gynecol 1991;164:1038–1043.
81.
Miki S, Iwano M, Miki Y, et al. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 1989;250:607–610.
82.